研發與技術
R&D and Technology
-
查看詳情 >
2023-A Phase Ib study of anti-EGFR antibody SCT200 in combination with anti-PD-1 antibody SCT-I10A for patients with RASBRAF wild-type static colorectal cancer
Colorectal cancer (CRC) is one of the most prevalent malignancies ...
2023-12-23 -
查看詳情 >
Efficacy Safety and Pharmacokinetics of Recombinant Human Coagulation Factor VIII (Omfiloctocog alfa) in Previously Treated Children with Severe Hemophilia A.
2022 - Omfiloctocog alfa the first China-developed recombinant fac...
2022-08-30 -
查看詳情 >
Rational Development of a Polysaccharide-Protein-Conjugated Nanoparticle Vaccine Against SARS-CoV-2 Variants and Streptococcus pneumoniae
2022 - The ongoing COVID-19 pandemic caused by SARS-CoV-2 has led ...
2022-08-30 -
查看詳情 >
Immunogenicity correlation in cynomolgus monkeys between Luminex‐d total IgG immunoassay and pseudovirion‐ d neutralization assay for a 14‐valent recombinant human papillomavirus vaccine
2022 - A new virus‐like particle d vaccine covering 14 types of hi...
2022-08-30 -
查看詳情 >
Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters
2022 - Monoclonal antibodies represent important weapons in our ar...
2022-08-30 -
查看詳情 >
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second line therapy in advanced esophageal squamous cell cancer
2022 - The mainstay treatment of esophageal squamous cell carcinom...
2022-08-30 -
查看詳情 >
基于免疫球蛋白G降解酶切和高效液相色譜的抗體電荷異構體分析技術
2021 - 探索和優化單克隆抗體電荷異構體分析的酶切預處理和高效液相色譜檢測方法。 方法：采用和優化基于Thermo ProPac...
2022-08-30 -
查看詳情 >
生物藥產業蓬勃發展早期的奠基性系統開發——緬懷王義翹教授的開創性研究和成就
2021 - 以單克隆抗體藥物及重組蛋白為代表的生物藥在腫瘤、自身免疫性疾病、病毒感染等多個重大疾病的預防及治療 領域發揮了重要作...
2021-08-30